Clinical Trial Detail

NCT ID NCT02028988
Title Enzalutamide + External Beam Rt For Prostate
Recruitment Active, not recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

prostate cancer

Therapies

Enzalutamide

Age Groups: adult

No variant requirements are available.